The reasons – and researcher – behind Pfizer’s decision to expand in Sanford


Pfizer's decision to invest $500 million into Sanford comes at the end of a long line of investment and work – but it also comes as the result of largely one Triangle researcher's work.

Previous Elanco/Bayer deal could be a 'big win' for KC — or a disaster
Next New home construction keeps falling in metro Denver